{"protocolSection":{"identificationModule":{"nctId":"NCT03001544","orgStudyIdInfo":{"id":"TS CP01-2015"},"organization":{"fullName":"Translational Sciences, Inc.","class":"INDUSTRY"},"briefTitle":"Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer","officialTitle":"Phase 1 Single-ascending Dose-escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Anti-alpha2-antiplasmin (α2AP) Monoclonal Antibody TS23 in Healthy Human Volunteers","acronym":"TS23Phase1a"},"statusModule":{"statusVerifiedDate":"2016-12","overallStatus":"UNKNOWN","lastKnownStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-07"},"primaryCompletionDateStruct":{"date":"2016-06","type":"ACTUAL"},"completionDateStruct":{"date":"2017-06","type":"ESTIMATED"},"studyFirstSubmitDate":"2016-11-11","studyFirstSubmitQcDate":"2016-12-20","studyFirstPostDateStruct":{"date":"2016-12-23","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-12-20","lastUpdatePostDateStruct":{"date":"2016-12-23","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Translational Sciences, Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"This study is designed to determine the safety, pharmacokinetics and pharmacodynamics of a single intravenous dose of TS23 in healthy adults.","detailedDescription":"This is a first-in-human, Phase 1 study of the safety, pharmacokinetics and pharmacodynamics of TS23 in healthy male volunteers.TS23 is a monoclonal antibody that inactivates alpha 2-antiplasmin. Four dose cohorts of six subjects will be studied in a single ascending dose trial at one clinical center."},"conditionsModule":{"conditions":["Thrombosis","Cerebral Ischemia","Venous Thrombosis","Pulmonary Embolism","Myocardial Infarction"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":24,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Experimental Ascending Dose Cohort","type":"EXPERIMENTAL","description":"TS23","interventionNames":["Biological: TS23"]}],"interventions":[{"type":"BIOLOGICAL","name":"TS23","description":"comparison of different doses","armGroupLabels":["Experimental Ascending Dose Cohort"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number and severity of adverse events post-dose","description":"To count the number and assess the severity of treatment emergent adverse events within 10 weeks post dose","timeFrame":"10 weeks"}],"secondaryOutcomes":[{"measure":"Coagulation (fibrinogen, PT, aPTT)","timeFrame":"10 weeks"},{"measure":"Anti-drug antibody","timeFrame":"16 weeks"},{"measure":"alpha2-antiplasmin activity","timeFrame":"10 weeks"},{"measure":"D-dimer","timeFrame":"10 weeks"},{"measure":"Pharmacokinetic parameter, maximum concentration of TS23","description":"Pharmacokinetic parameter Cmax of TS23 in plasma","timeFrame":"10 weeks"},{"measure":"Pharmacokinetic parameter, half-life of TS23","description":"Pharmacokinetic parameter, time required for TS23 concentrations to fall by half","timeFrame":"10 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Able to provide written informed consent\n* Healthy males age 18 years to 60 years of age\n* Body mass index ≥ 20 and ≤ 33 kg/m squared\n\nExclusion Criteria:\n\n* Known allergies or hypersensitivities to blood products or derivatives or therapeutic proteins or product excipients or components of CHO cells\n* Current alcohol or drug abuse or history of alcohol or drug abuse\n* Participation in any trial with an investigational drug within 90 days prior to dosing\n* Blood donation of more than 500 mL of blood within 90 days prior to dosing\n* Any history of a bleeding or thrombotic disorder\n* Any history of significant cardiac, pulmonary, renal, hepatic, neurologic, or immunologic disorder\n* Over-the-counter medications, dietary supplements and herbal products (except a daily vitamin) within 14 days of drug administration or during the study\n* No prescription medication for at least 14 days or 5-half-lives, whichever is longer, prior to study drug administration.\n* Use of anticoagulants, fibrinolytic agents or non-steroidal anti-inflammatory medicines (except aspirin doses of 82 mg per day or less) for 2 weeks prior to and during the study\n* Known hereditary fructosemia (due to sorbitol in the formulation)\n* Any previous or current monoclonal antibody therapy\n* History of trauma or surgery within the past 60 days or planned surgery within 30 days\n* Abnormal baseline laboratory values or any laboratory values deemed clinically significant by the Investigator\n* Recent history of head trauma in last 30 days prior to receiving TS23\n* Unwillingness or inability to avoid contact sports or other activities with more than a small risk of head or facial trauma within 30 days of receiving TS23\n* History of or risk of falls (e.g., due to dementia, frailty, etc.)\n* Sexually active subjects must agree to use a reliable method of birth control (abstinence, condoms, vasectomy) and to not donate sperm for 3 months after receiving TS23","healthyVolunteers":true,"sex":"MALE","minimumAge":"18 Years","maximumAge":"60 Years","stdAges":["ADULT"]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000011655","term":"Pulmonary Embolism"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000009203","term":"Myocardial Infarction"},{"id":"D000013927","term":"Thrombosis"},{"id":"D000004617","term":"Embolism"},{"id":"D000020246","term":"Venous Thrombosis"},{"id":"D000007238","term":"Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000009336","term":"Necrosis"},{"id":"D000017202","term":"Myocardial Ischemia"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000016769","term":"Embolism and Thrombosis"},{"id":"D000008171","term":"Lung Diseases"},{"id":"D000012140","term":"Respiratory Tract Diseases"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000020521","term":"Stroke"}],"browseLeaves":[{"id":"M14199","name":"Pulmonary Embolism","asFound":"Pulmonary Embolism","relevance":"HIGH"},{"id":"M16376","name":"Thrombosis","asFound":"Thrombosis","relevance":"HIGH"},{"id":"M7474","name":"Embolism","asFound":"Embolism","relevance":"HIGH"},{"id":"M21761","name":"Venous Thrombosis","asFound":"Venous Thrombosis","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemia","relevance":"HIGH"},{"id":"M11845","name":"Myocardial Infarction","asFound":"Myocardial Infarction","relevance":"HIGH"},{"id":"M9972","name":"Infarction","asFound":"Infarction","relevance":"HIGH"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Cerebral Ischemia","relevance":"HIGH"},{"id":"M5484","name":"Brain Ischemia","asFound":"Cerebral Ischemia","relevance":"HIGH"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M6236","name":"Coronary Artery Disease","relevance":"LOW"},{"id":"M19196","name":"Myocardial Ischemia","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M18818","name":"Embolism and Thrombosis","relevance":"LOW"},{"id":"M10858","name":"Lung Diseases","relevance":"LOW"},{"id":"M14667","name":"Respiratory Tract Diseases","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M21996","name":"Stroke","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC10","name":"Nervous System Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M3915","name":"Antibodies","relevance":"LOW"},{"id":"M3920","name":"Antibodies, Monoclonal","relevance":"LOW"},{"id":"M9874","name":"Immunoglobulins","relevance":"LOW"},{"id":"M3942","name":"Antifibrinolytic Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Coag","name":"Coagulants"}]}},"hasResults":false}